These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34803162)

  • 1. Invited Commentary on "My Research Results: a program to facilitate return of clinically actionable genomic research findings" by Willis et al.
    Biesecker LG
    Eur J Hum Genet; 2022 Mar; 30(3):256-257. PubMed ID: 34803162
    [No Abstract]   [Full Text] [Related]  

  • 2. My Research Results: a program to facilitate return of clinically actionable genomic research findings.
    Willis AM; Terrill B; Pearce A; McEwen A; Ballinger ML; Young MA
    Eur J Hum Genet; 2022 Mar; 30(3):363-366. PubMed ID: 34602610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Return of genetic and genomic research findings: experience of a pediatric biorepository.
    Papaz T; Liston E; Zahavich L; Stavropoulos DJ; Jobling RK; Kim RH; Reuter M; Miron A; Oechslin E; Mondal T; Bergin L; Smythe JF; Altamirano-Diaz L; Lougheed J; Yao R; Akinrinade O; Breckpot J; Mital S
    BMC Med Genomics; 2019 Nov; 12(1):173. PubMed ID: 31775751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically Actionable Findings Derived From Predictive Genomic Testing Offered in a Medical Practice Setting.
    Anderson JL; Kruisselbrink TM; Lisi EC; Hughes TM; Steyermark JM; Winkler EM; Berg CM; Vierkant RA; Gupta R; Ali AH; Faubion SS; Aoudia SL; McAllister TM; Farrugia G; Stewart AK; Lazaridis KN
    Mayo Clin Proc; 2021 Jun; 96(6):1407-1417. PubMed ID: 33890576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescent and Parental Attitudes About Return of Genomic Research Results: Focus Group Findings Regarding Decisional Preferences.
    McGowan ML; Prows CA; DeJonckheere M; Brinkman WB; Vaughn L; Myers MF
    J Empir Res Hum Res Ethics; 2018 Oct; 13(4):371-382. PubMed ID: 29806518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician interpretation of genomic test results and treatment selection.
    Brusco LL; Wathoo C; Mills Shaw KR; Holla VR; Bailey AM; Johnson AM; Khotskaya YB; Litzenburger BC; Sanchez NS; Zeng J; Bernstam EV; Eng C; Kee BK; Amaria RN; Routbort MJ; Mills GB; Mendelsohn J; Meric-Bernstam F
    Cancer; 2018 Mar; 124(5):966-972. PubMed ID: 29165790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of aortic disease biorepository participants' preferences for return of research genetic results.
    Love-Nichols J; Uhlmann WR; Arscott P; Willer C; Hornsby W; Roberts JS
    J Genet Couns; 2021 Jun; 30(3):645-655. PubMed ID: 33319384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of pathogenic variants in clinically actionable genes in a founder population.
    Lynch MT; Maloney KA; Pollin TI; Streeten EA; Xu H; ; Shuldiner AR; Van Hout CV; Gonzaga-Jauregui C; Mitchell BD
    Am J Med Genet A; 2021 Nov; 185(11):3476-3484. PubMed ID: 34467620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Return of Results Policies for Genomic Research: Current Practices and the Hearts in Rhythm Organization (HiRO) Approach.
    Comber DA; Davies B; Roberts JD; Tadros R; Green MS; Healey JS; Simpson CS; Sanatani S; Steinberg C; MacIntyre C; Angaran P; Duff H; Hamilton R; Arbour L; Leather R; Seifer C; Fournier A; Atallah J; Kimber S; Makanjee B; Alqarawi W; Cadrin-Tourigny J; Joza J; Gibbs K; Robb L; Zahavich L; Gardner M; Talajic M; Virani A; Krahn AD; Lehman A; Laksman ZWM
    Can J Cardiol; 2022 Apr; 38(4):526-535. PubMed ID: 34715283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Medically Actionable Secondary Findings in the 1000 Genomes.
    Olfson E; Cottrell CE; Davidson NO; Gurnett CA; Heusel JW; Stitziel NO; Chen LS; Hartz S; Nagarajan R; Saccone NL; Bierut LJ
    PLoS One; 2015; 10(9):e0135193. PubMed ID: 26332594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study.
    Haverfield EV; Esplin ED; Aguilar SJ; Hatchell KE; Ormond KE; Hanson-Kahn A; Atwal PS; Macklin-Mantia S; Hines S; Sak CW; Tucker S; Bleyl SB; Hulick PJ; Gordon OK; Velsher L; Gu JYJ; Weissman SM; Kruisselbrink T; Abel C; Kettles M; Slavotinek A; Mendelsohn BA; Green RC; Aradhya S; Nussbaum RL
    BMC Med; 2021 Aug; 19(1):199. PubMed ID: 34404389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Findings for Cancer Risk.
    Willis AM; Smith SK; Meiser B; Ballinger ML; Thomas DM; Tattersall M; ; ; Young MA
    J Genet Couns; 2018 Sep; 27(5):1055-1066. PubMed ID: 29455319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.
    Berg JS; Amendola LM; Eng C; Van Allen E; Gray SW; Wagle N; Rehm HL; DeChene ET; Dulik MC; Hisama FM; Burke W; Spinner NB; Garraway L; Green RC; Plon S; Evans JP; Jarvik GP;
    Genet Med; 2013 Nov; 15(11):860-7. PubMed ID: 24195999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings.
    Seifert BA; O'Daniel JM; Amin K; Marchuk DS; Patel NM; Parker JS; Hoyle AP; Mose LE; Marron A; Hayward MC; Bizon C; Wilhelmsen KC; Evans JP; Earp HS; Sharpless NE; Hayes DN; Berg JS
    Clin Cancer Res; 2016 Aug; 22(16):4087-4094. PubMed ID: 27083775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic inheritances: disclosing individual research results from whole-exome sequencing to deceased participants' relatives.
    Chan B; Facio FM; Eidem H; Hull SC; Biesecker LG; Berkman BE
    Am J Bioeth; 2012; 12(10):1-8. PubMed ID: 22974017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary: We've only just begun: unravelling the underlying genetics of neurodevelopmental disorders--a commentary on Kiser et al. (2015).
    Coghill D
    J Child Psychol Psychiatry; 2015 Mar; 56(3):296-8. PubMed ID: 25714739
    [No Abstract]   [Full Text] [Related]  

  • 17. Genomic medicine: health care issues and the unresolved ethical and social dilemmas.
    Idemyor V
    Am J Ther; 2014; 21(6):548-53. PubMed ID: 22713532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Returning individual genomic results to population-based cohort study participants with BRCA1/2 pathogenic variants.
    Ohneda K; Hamanaka Y; Kawame H; Fuse N; Nagami F; Suzuki Y; Yamaguchi-Kabata Y; Shimada M; Masamune A; Aoki Y; Ishida T; Yamamoto M
    Breast Cancer; 2023 Jan; 30(1):110-120. PubMed ID: 36161580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing clinical exome design and parallel gene-testing for recessive genetic conditions in preconception carrier screening: Translational research genomic data from 14,125 exomes.
    Capalbo A; Valero RA; Jimenez-Almazan J; Pardo PM; Fabiani M; Jiménez D; Simon C; Rodriguez JM
    PLoS Genet; 2019 Oct; 15(10):e1008409. PubMed ID: 31589614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Return of individual research results from genomic research: A systematic review of stakeholder perspectives.
    Vears DF; Minion JT; Roberts SJ; Cummings J; Machirori M; Blell M; Budin-Ljøsne I; Cowley L; Dyke SOM; Gaff C; Green R; Hall A; Johns AL; Knoppers BM; Mulrine S; Patch C; Winkler E; Murtagh MJ
    PLoS One; 2021; 16(11):e0258646. PubMed ID: 34748551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.